{{Drugbox
| IUPAC_name = ''N''-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-5-(4-fluorophenyl)-1''H''-pyrazole-3-carboxamide
| image = 5F-AB-FUPPYCA.svg

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = Schedule II
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = 
| legal_NZ = 
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number =None <!-- as of 20/nov/15 -->
| ATC_prefix =  
| ATC_suffix =  
| PubChem =  
| ChemSpiderID      = 58191440
| smiles            = NC(C(C(C)C)NC(=O)C1=NN(C(=C1)C1=CC=C(C=C1)F)CCCCCF)=O
| StdInChI          = 1/C20H26F2N4O2/c1-13(2)18(19(23)27)24-20(28)16-12-17(14-6-8-15(22)9-7-14)26(25-16)11-5-3-4-10-21/h6-9,12-13,18H,3-5,10-11H2,1-2H3,(H2,23,27)(H,24,28)/f/h24H,23H2
| StdInChIKey       = GSXRDTDYPSATDE-UHFFFAOYSA-N

<!--Chemical data-->
| C=20 | H=26 | F=2 | N=4 | O=2
| molecular_weight = 392.45 g/mol
}}

'''5F-AB-FUPPYCA''' (also known as '''AZ-037''') is a [[pyrazole]]-based [[synthetic cannabinoid]] that is presumed to be a potent [[agonist]] of the [[CB1 receptor|CB<sub>1</sub> receptor]] and has been sold online as a [[designer drug]].<ref>{{cite journal|first1=Ulrich|last1=Girreser|first2=Peter|last2=Rösner|first3=Andrej|last3=Vasilev|title=Structure elucidation of the designer drug N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-3-(4-fluorophenyl)-pyrazole-5-carboxamide and the relevance of predicted 13C NMR shifts – a case study|url=http://onlinelibrary.wiley.com/doi/10.1002/dta.1820/abstract|journal=Drug Testing and Analysis|date=July 2016|issn=1942-7611|pages=668–675|volume=8|issue=7|doi=10.1002/dta.1820|pmid=26012418}}</ref><ref>{{cite journal|first1=Samuel D.|last1=Banister|first2=Mitchell|last2=Longworth|first3=Richard|last3=Kevin|first4=Shivani|last4=Sachdev|title=Pharmacology of Valinate and ''tert''-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues|url=http://pubs.acs.org/doi/abs/10.1021/acschemneuro.6b00137|journal=ACS Chemical Neuroscience|date=27 July 2016|doi=10.1021/acschemneuro.6b00137|pmid=27421060|first5=Marina|last5=Santiago|first6=Jordyn|last6=Stuart|first7=James B. C.|last7=Mack|first8=Michelle|last8=Glass|first9=Iain S.|last9=McGregor|first10=Mark|last10=Connor|first11=Michael|last11=Kassiou|volume=7|pages=1241–54}}</ref> It was first detected by the [[European Monitoring Centre for Drugs and Drug Addiction|EMCDDA]] as part of a seizure of 540&nbsp;g white powder in France in February 2015.<ref>{{cite web | url=http://drogfokuszpont.hu/wp-content/uploads/NFP_hirlevel_2015_junius.pdf | title=2015. ÉVI EURÓPAI KÁBÍTÓSZER - JELENTÉS - A MONITOROZÁS 20 ÉVE | publisher=Hungarian National Focal Point (NFP) | date=June 2015 | accessdate=23 July 2015}}</ref> The name '''AZ-037''' is also used as a synonym for its structural isomer 5-fluoro-3,5-AB-PFUPPYCA on the Cayman Chemical website.<ref>{{cite web | url=https://www.caymanchem.com/product/17181 | title=5-fluoro-3,5-AB-PFUPPYCA | publisher=Cayman Chemical Company | accessdate=11 February 2016}}</ref> Thus '''AZ-037''' is being used as a synonym for two different compounds.

==See also==
{{div col|colwidth=30em}}
* 5F-3,5-AB-PFUPPYCA
* [[AB-CHFUPYCA]]
* [[AB-FUBINACA]]
* [[ADB-FUBINACA]]
* [[AMB-FUBINACA]]
* [[APP-FUBINACA]]
* [[FDU-NNE1]]
* [[FUB-144]]
* [[FUB-APINACA]]
* [[FUB-JWH-018]]
* [[FUB-NNE1]]
* [[FDU-PB-22]]
* [[FUB-PB-22]]
* [[MDMB-FUBICA]]
* [[MDMB-FUBINACA]]
{{Div col end}}

==References==
{{reflist}}

{{Cannabinoids}}

[[Category:Cannabinoids]]
[[Category:Designer drugs]]
[[Category:Fluoroarenes]]
[[Category:Pyrazoles]]
[[Category:Pyrazolecarboxamides]]
[[Category:Organofluorides]]


{{cannabinoid-stub}}